The United States Centers for Medicare & Medicaid Services announced that all employees of healthcare facilities that accept payment from Medicare and/or Medicaid must be vaccinated against COVID-19 by January 4, 2022. There is no…

The United States government committed to purchasing 1.7 million doses of molnupiravir—the Merck antiviral medication for COVID-19—in June, and has since increased its order by 1.4 million doses. Molnupiravir has been shown to decrease…

As the consistent growth in COVID-19 cases driven by the Delta variant seems to have abated, an analysis of this deadly surge is now possible. The most significant takeaway is that the unvaccinated faced the highest rates of morbidity and…

While therapeutic mouthrinse is often prescribed to help control oral biofilm and for other preventive uses, researchers continue to investigate whether such rinses may reduce or help neutralize SARS-CoV-2 in the oral cavity. A study by…

According to the United States Centers for Disease Control and Prevention, about 2,000 US workers sustain a job-related eye injury each day that requires medical treatment. This includes oral health professionals, who are subject to…

According to a study in The Lancet, COVID-19 brought more than viral illness, lockdowns, and business disruptions, it also led to an increase in mental health problems. Researchers reported 76 million more cases of anxiety disorders and 53…

One of the most significant unanswered questions of the global pandemic is why some people experience mild symptoms while others become seriously ill and even die. The answer may be in our genes. Researchers from the United Kingdom have…

On the heels of the United Kingdom’s authorization of a competing medication by Merck, Pfizer announced that its own antiviral drug designed to treat COVID-19 shows promising results. According to the company’s clinical trial on 775 adults…

The United Kingdom (UK) has authorized the use of an antiviral medication, molnupiravir, to reduce the severity of illness associated with COVID-19. Manufactured by the American pharmaceutical company, Merck, molnupiravir has been shown to…

Many public health experts suggest that the COVID-19 pandemic will come to a close by the end of 2022, and while it will not disappear, the pandemic will mutate into an endemic disease. This change will mean that most people will have…